We are an independent, global full-service contract research organization (“CRO”) offering a comprehensiveportfolio of services across various stages of the drug development value chain ranging from non-clinical and preclinicaldevelopment and testing to early phase clinical pharmacology, bioavailability and bioequivalence studiesand early to late phase clinical trials for different modalities of drugs including novel chemical entities, novelbiological entities, generics and biosimilars besides medical devices. Our services include: (i) early phase and latephase clinical trials (“Clinical Trials”); (ii) Healthy volunteer studies (“HVS”) which includes bioavailabilitystudies and bioequivalence studies; (iii) pre-clinical trials and non-clinical testing (“Pre-Clinical”); and (iv)biopharma services which includes non-clinical analysis and clinical bioanalysis of large molecules (“BiopharmaServices”). We are present across the key global markets including North America, Europe and Asia, includingIndia.
7. Project Name: Capital expenditure towards procurement of equipment and machinery
Project Cost: 500
8. Project Name: Investment in our Material Subsidiary, Bioneeds India Private Limited
Project Cost: 350
9. Project Name: Investment in our Material Subsidiary, Bioneeds India Private Limited
Project Cost: 108.87
10. Project Name: Funding organic growth of our Company, our Material Subsidiary,
Project Cost: 330
Data not availble